Brain perfusion and permeability in patients with advanced, refractory glioblastoma treated with lomustine and the transforming growth factor‑β receptor I kinase inhibitor LY2157299 monohydrate

  1. Sepulveda-Sanchez, J.
  2. Ramos, A.
  3. Hilario, A.
  4. De Velasco, G.
  5. Castellano, D.
  6. De La Torre, M.G.
  7. Rodon, J.
  8. Lahn, M.F.
Journal:
Oncology Letters

ISSN: 1792-1082 1792-1074

Year of publication: 2015

Volume: 9

Issue: 6

Pages: 2442-2448

Type: Article

DOI: 10.3892/OL.2015.3106 GOOGLE SCHOLAR lock_openOpen access editor